NCT05101174

Brief Summary

The current project is a single-blinded, double-arm, 6-month randomized controlled trial aiming to assess the effects of a integrated intervention program on neurocognitive function with respect to event-related potential in adults aged 45-70 years. Additionally, the potential impacts of apolipoprotein epsilon-4 alleles and the brain-derived neurotrophic factor will be explored.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 1, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

April 11, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

November 27, 2023

Status Verified

November 1, 2023

Enrollment Period

2.9 years

First QC Date

September 26, 2021

Last Update Submit

November 23, 2023

Conditions

Keywords

physical fitnessmeditationsocial interactionApolipoprotein Eagingevent-related potential

Outcome Measures

Primary Outcomes (2)

  • Inhibition: Changes in Stroop test performance

    The computerized Stroop test is administrated to assess participants' inhibitory function, and the changes in Stroop test performance from baseline to end of the intervention (i.e., month 6) will be examined.

    30 minutes each at the baseline and at month 6

  • Changes in neuroelectrical activities

    The neuroelectrical activities during the computerized cognitive tasks is recorded and analyzed using the Neuroscan system. Changes in the neuroelectrical activities from baseline to end of the intervention (i.e., month 6) will be examined.

    60 minutes each at baseline and at month 6

Secondary Outcomes (9)

  • ApoE genotype

    5 minutes at baseline

  • Blood neurotrophic marker: Changes in brain-derived neurotrophic factor (BDNF) levels

    5 minutes each at baseline and at month 6

  • Physical fitness measurements: Changes in aerobic fitness

    30 minutes each at baseline and at month 6

  • Physical fitness measurements: Changes in muscular fitness

    15 minutes each at baseline and at month 6

  • Physical fitness measurements: Changes in flexibility

    15 minutes each at baseline and at month 6

  • +4 more secondary outcomes

Study Arms (2)

Integrated Intervention Group (IIG)

EXPERIMENTAL

The IIG attends 150 min exercise per week, which consists of one 90-min trainer-supervised program and multiple online sessions, for 6 months. Intervention: aerobic exercise, resistance exercise, coordinative exercise, flexibility, social interaction, and meditation.

Behavioral: Integrated Intervention Group (IIG)

Control Group

OTHER

The control group is invited to attend one 60-min online educational course per week for 6 months. Intervention: 60-min online educational program.

Behavioral: Control Group

Interventions

The IIG attends 150 min exercise per week, which consists of one 90-min trainer-supervised session and multiple online sessions for 6 months. Each session consists of (1) warm-up, (2) resistance exercise and flexibility exercise, (3) resistance exercise and coordinative exercise from the "Eastern exercise" perspective, (4) social interaction exercise, and (5) cool-down and meditation.

Integrated Intervention Group (IIG)
Control GroupBEHAVIORAL

The Control Group is informed to maintain their lifestyles and invited to attend one 60-min online educational course per week. The participants are required to provide their physical activity behavior once every month for 6 months (6 times).

Control Group

Eligibility Criteria

Age45 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Normal or corrected-to-normal vision
  • Able to speak and read Chinese
  • Scores of Mini-Mental Status Examination \>= 25
  • Physical Activity Readiness Questionnaire score \< 0
  • Able to conduct the exercise with moderate intensity
  • Provide informed consent

You may not qualify if:

  • Diagnosed or self-reported cognitive problems (e.g., mild cognitive impairment or dementia)
  • Diagnosed or self-reported physical disease (e.g., untreated hypertension and chronic heart disease, stroke, brain tumor, musculoskeletal disorders, other exercise contradictions)
  • Diagnosed or self-reported major psychiatric illness (e.g., major depression, schizophrenia)
  • Diagnosed or self-reported neurodegenerative disease (e.g., Alzheimer's disease or other dementias, Parkinson's disease (PD) and PD-related disorders, Huntington's disease)
  • History of alcohol or drug abuse
  • History of chemotherapy
  • Traveling consecutively for three weeks or more during the study
  • Unwillingness to be randomized to one of the two groups
  • Currently participating in another study trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Yu-Kai Chang

Taipei, 106, Taiwan

NOT YET RECRUITING

Yu-Kai Normal Chang

Taipei, 162, Taiwan

RECRUITING

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Yu-Kai Chang, PhD

    Department of Physical Education and Sport Sciences, National Taiwan Normal University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yu-Kai Chang, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 26, 2021

First Posted

November 1, 2021

Study Start

April 11, 2022

Primary Completion

March 1, 2025

Study Completion

September 1, 2025

Last Updated

November 27, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations